VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
2.770
+0.070 (2.59%)
At close: Jan 21, 2025, 4:00 PM
2.900
+0.130 (4.70%)
After-hours: Jan 21, 2025, 6:13 PM EST
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $40.86 million as of January 21, 2025. Its market cap has increased by 26.74% in one year.
Market Cap
40.86M
Enterprise Value
-28.91M
1-Year Change
26.74%
Ranking
Category
Stock Price
$2.77
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $40.86M, a decrease of -82.21%. That is a compound annual growth rate of -29.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 39.83M | -19.40% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | 265.25M | 15.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |